List view / Grid view
Researchers reveal that activating the MHC class II transactivator (CIITA) and CD74 genes protected cells against infection by Ebola and SARS-CoV-2.
Drug Target Review rounds up the latest announcements regarding funding for research into COVID-19 treatments and vaccines.
A new report has stated that the majority of medical journals restrict their content for pharmaceutical industry professionals.
Broadly neutralising antibody treatment may target viral reservoir in monkeys...
Researchers have identified four pathogens that are responsible for the vast majority of diarrheal illnesses - leading the way for potential new treatments...
A collaborative team of scientists have developed a novel synthetic vaccine with a method grown in plants that uses virus-like particles...
Daiichi Sankyo has entered into a new joint research agreement with the Drugs for Neglected Diseases initiative (DNDi) with regard to a new research program, the Hit-to-Lead Project, with the aim of developing drug treatments for two neglected tropical diseases, leishmaniasis and Chagas disease.
